Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 45 |
Updated: | 12/28/2013 |
Contact: | Roger Morgan, MD, FACS |
Email: | Contact@kowaus.com |
Phone: | 919-433-1600 |
This study will test single doses of the study drug in increasing amounts to see if it is
safe.
safe.
Inclusion Criteria:
- Subject provides written informed consent before any study-specific evaluation is
performed.
- Subject is a healthy adult male or a female of non-childbearing potential between the
ages of 18 and 45 years, inclusive.
- Subject has a body mass index of 18.5 to 32 kg/m2, inclusive.
Exclusion Criteria:
- Subject is a woman who is of childbearing potential or is breastfeeding.
- Subject has the presence of an active or recurring clinically significant
cardiovascular, pulmonary, renal, endocrine, hepatic, neurologic, psychiatric,
immunologic, hematologic, gastrointestinal, or metabolic disease requiring medical
treatment.
We found this trial at
1
site
Click here to add this to my saved trials